New Method for Detecting VEGF Using Antibodies
Author Information
Author(s): Khaligh Soodeh Salimi, Khalid-Salako Fahd, Kurt Hasan, Yüce Meral
Primary Institution: Sabanci University, Istanbul, Türkiye
Hypothesis
Can biotinylated FcγRI improve the detection of VEGF using SPR technology?
Conclusion
The study demonstrates a new biosensor that effectively detects VEGF, showing potential for clinical diagnostics.
Supporting Evidence
- VEGF is a critical biomarker for cancer and other diseases.
- The new biosensor achieved sensitivity at the picomolar level.
- Specificity for VEGF was confirmed over other proteins.
- The calibration curve demonstrated accurate VEGF quantification.
- Regeneration of the sensor surface was successfully optimized.
Takeaway
This study created a new way to find a protein called VEGF that helps doctors understand cancer better, using special sensors and antibodies.
Methodology
The study used surface plasmon resonance (SPR) to analyze the binding of biotinylated FcγRI to IgG1-type antibodies and VEGF.
Limitations
The biosensor's sensitivity is limited compared to some traditional methods like ELISA.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95%
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website